SARS-CoV-2 neutralizing antibody responses are more robust in patients with severe disease

被引：87

作者：

Wang, Pengfei ^{[1
]}

Liu, Lihong ^{[1
]}

Nair, Manoj S. ^{[1
]}

Yin, Michael T. ^{[2
]}

Luo, Yang ^{[1
]}

Wang, Qian ^{[3
]}

Yuan, Ting ^{[1
]}

Mori, Kanako ^{[1
]}

Solis, Axel Guzman ^{[1
]}

Yamashita, Masahiro ^{[1
]}

Garg, Ankur ^{[4
]}

Purpura, Lawrence J. ^{[2
]}

Laracy, Justin C. ^{[2
]}

Yu, Jian ^{[1
]}

Joshua-Tor, Leemor ^{[4
]}

Sodroski, Joseph ^{[3
]}

Huang, Yaoxing ^{[1
]}

Ho, David D. ^{[1
]}

机构：

[1] Columbia Univ, Vagelos Coll Phys & Surg, Aaron Diamond AIDS Res Ctr, 701 W 168th St, New York, NY 10032 USA

[2] Columbia Univ, Vagelos Coll Phys & Surg, Dept Internal Med, Div Infect Dis, New York, NY USA

[3] Harvard Med Sch, Dept Microbiol, Dana Farber Canc Inst, Dept Canc Immunol & Virol, Boston, MA 02115 USA

[4] Cold Spring Harbor Lab, WM Keck Struct Biol Lab, POB 100, Cold Spring Harbor, NY 11724 USA

来源：

EMERGING MICROBES & INFECTIONS | 2020年 / 9卷 / 01期

基金：

美国国家卫生研究院;

关键词：

SARS-CoV-2; antibody; neutralization; severe; non-severe;

D O I：

10.1080/22221751.2020.1823890

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

We studied plasma antibody responses of 35 patients about 1 month after SARS-CoV-2 infection. Titers of antibodies binding to the viral nucleocapsid and spike proteins were significantly higher in patients with severe disease. Likewise, mean antibody neutralization titers against SARS-CoV-2 pseudovirus and live virus were higher in the sicker patients, by similar to 5-fold and similar to 7-fold, respectively. These findings have important implications for those pursuing plasma therapy, isolation of neutralizing monoclonal antibodies, and determinants of immunity.

引用

页码：2091 / 2093

页数：3

共 50 条

[41] Antibody responses after SARS-CoV-2 vaccination in patients with lymphoma
Lim, Sean H.
Campbell, Nicola
Johnson, Marina
Joseph-Pietras, Debora
Collins, Graham P.
O'Callaghan, Ann
Fox, Christopher P.
Ahearne, Matthew
Johnson, Peter W. M.
Goldblatt, David
Davies, Andrew J.
LANCET HAEMATOLOGY, 2021, 8 (08): : E542 - E544
[42] EVALUATION OF ANTIBODY RESPONSES TO SARS-COV-2 VACCINES IN PATIENTS WITH CKD
Abdullaev, Sherzod
Sharapov, Olimkhon
Igamberdieva, Ranokhon
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2023, 38 : I1181 - I1182
[43] Antibody responses to SARS-CoV-2 in patients with COVID-19
Long, Quan-Xin
Liu, Bai-Zhong
Deng, Hai-Jun
Wu, Gui-Cheng
Deng, Kun
Chen, Yao-Kai
Liao, Pu
Qiu, Jing-Fu
Lin, Yong
Cai, Xue-Fei
Wang, De-Qiang
Hu, Yuan
Ren, Ji-Hua
Tang, Ni
Xu, Yin-Yin
Yu, Li-Hua
Mo, Zhan
Gong, Fang
Zhang, Xiao-Li
Tian, Wen-Guang
Hu, Li
Zhang, Xian-Xiang
Xiang, Jiang-Lin
Du, Hong-Xin
Liu, Hua-Wen
Lang, Chun-Hui
Luo, Xiao-He
Wu, Shao-Bo
Cui, Xiao-Ping
Zhou, Zheng
Zhu, Man-Man
Wang, Jing
Xue, Cheng-Jun
Li, Xiao-Feng
Wang, Li
Li, Zhi-Jie
Wang, Kun
Niu, Chang-Chun
Yang, Qing-Jun
Tang, Xiao-Jun
Zhang, Yong
Liu, Xia-Mao
Li, Jin-Jing
Zhang, De-Chun
Zhang, Fan
Liu, Ping
Yuan, Jun
Li, Qin
Hu, Jie-Li
Chen, Juan
NATURE MEDICINE, 2020, 26 (06) : 845 - +
[44] Antibody responses to SARS-CoV-2 in patients with COVID-19
Quan-Xin Long
Bai-Zhong Liu
Hai-Jun Deng
Gui-Cheng Wu
Kun Deng
Yao-Kai Chen
Pu Liao
Jing-Fu Qiu
Yong Lin
Xue-Fei Cai
De-Qiang Wang
Yuan Hu
Ji-Hua Ren
Ni Tang
Yin-Yin Xu
Li-Hua Yu
Zhan Mo
Fang Gong
Xiao-Li Zhang
Wen-Guang Tian
Li Hu
Xian-Xiang Zhang
Jiang-Lin Xiang
Hong-Xin Du
Hua-Wen Liu
Chun-Hui Lang
Xiao-He Luo
Shao-Bo Wu
Xiao-Ping Cui
Zheng Zhou
Man-Man Zhu
Jing Wang
Cheng-Jun Xue
Xiao-Feng Li
Li Wang
Zhi-Jie Li
Kun Wang
Chang-Chun Niu
Qing-Jun Yang
Xiao-Jun Tang
Yong Zhang
Xia-Mao Liu
Jin-Jing Li
De-Chun Zhang
Fan Zhang
Ping Liu
Jun Yuan
Qin Li
Jie-Li Hu
Juan Chen
Nature Medicine, 2020, 26 : 845 - 848
[45] Characteristics of neutralizing antibody titers of the SARS-CoV-2 vaccine in maintenance hemodialysis patients
Amari, Yoshifumi
Morimoto, Satoshi
Teranishi, Takashi
Motoike, Yu
Yurugi, Takatomi
Oyama, Yasuo
Nakajima, Fumitaka
Kobayashi, Hitoshi
CLINICAL NEPHROLOGY, 2024, 101 (06) : 271 - 276
[46] Poor neutralizing antibody responses in 106 patients with WM after vaccination against SARS-CoV-2: a prospective study
Gavriatopoulou, Maria
Terpos, Evangelos
Ntanasis-Stathopoulos, Ioannis
Briasoulis, Alexandros
Gumeni, Sentiljana
Malandrakis, Panagiotis
Fotiou, Despina
Migkou, Magdalini
Theodorakakou, Foteini
Eleutherakis-Papaiakovou, Evangelos
Kanellias, Nikolaos
Kastritis, Efstathios
Trougakos, Ioannis P.
Dimopoulos, Meletios A.
BLOOD ADVANCES, 2021, 5 (21) : 4398 - 4405
[47] Neutralizing Antibody Responses to SARS-CoV-2 in Korean Patients Who Have Recovered from COVID-19
Kim, Yoon-Jung
Bae, Joon-Yong
Bae, Sohyun
Hwang, Soyoon
Kwon, Ki Tae
Chang, Hyun-Ha
Lee, Won Kee
Cui, Chunguang
Lee, Gee Eun
Kim, Shin-Woo
Park, Man-Seong
YONSEI MEDICAL JOURNAL, 2021, 62 (07) : 584 - 592
[48] Non-glycosylated SARS-CoV-2 RBD elicited a robust neutralizing antibody response in mice
Ke, Qian
Sun, Peng
Wang, Tiantian
Mi, Taotao
Xu, Huifang
Wu, Jun
Liu, Bo
JOURNAL OF IMMUNOLOGICAL METHODS, 2022, 506
[49] Characterization of the neutralizing antibody response in SARS-CoV-2 infected individuals
Mamede, J.
Ash, M.
Gambut, S.
Melani, R.
Dharan, A.
Tarhoni, I.
Fhied, C.
Goo, Y. Ah
Campbell, E.
Al-Harthi, L.
Kelleher, N.
Borgia, J.
Schneider, J.
JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2021, 24
[50] Robust neutralizing antibodies to SARS-CoV-2 infection persist for months
Wajnberg, Ania
Amanat, Fatima
Firpo, Adolfo
Altman, Deena R.
Bailey, Mark J.
Mansour, Mayce
McMahon, Meagan
Meade, Philip
Mendu, Damodara Rao
Muellers, Kimberly
Stadlbauer, Daniel
Stone, Kimberly
Strohmeier, Shirin
Simon, Viviana
Aberg, Judith
Reich, David L.
Krammer, Florian
Cordon-Cardo, Carlos
SCIENCE, 2020, 370 (6521) : 1227 - +

← 1 2 3 4 5 →